|
Market Closed -
Euronext Paris
11:55:00 2026-10-06 am EDT
|
After hours 04:00:00 pm | |||
| 70.61 EUR | +0.89% |
|
70.38 | -0.33% |
| 03:22am | Sanofi : Berenberg remains its Buy rating | ZD |
| 01:57am | Vaccine seasonality to weigh on Sanofi in third quarter |  |
| Market Cap | 84.6B 95.3B 79.17B 71.76B 136B 9,187B 136B 951B 370B 4,686B 358B 350B 15,066B | P/E 2026 * |
11.2x | P/E 2027 * | 9.78x |
|---|---|---|---|---|---|
| Enterprise Value | 96.73B 109B 90.52B 82.04B 155B 10,504B 156B 1,087B 423B 5,358B 409B 400B 17,226B | EV / Sales 2026 * |
2.03x | EV / Sales 2027 * | 1.84x |
| Free-Float |
88.34% | Yield 2026 * |
6.03% | Yield 2027 * | 6.37% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| SAN | Real-time | |
CBOE
| SAN | Real-time | |
|
Xetra
| SNW | Delayed | |
|
Tradegate
| SNW | Real-time | |
|
Borsa Italiana
| 1SAN | End-of-day quote | |
|
Boerse Muenchen
| SNW | Real-time | |
|
Börse Stuttgart
| SNW | Delayed | |
|
Wiener Boerse
| SANO | End-of-day quote | |
|
Deutsche Boerse AG
| SNW | Delayed | |
|
OTC Markets
| SNYNF | Delayed | |
|
Mexican S.E.
| SAN1 N | End-of-day quote | |
|
CBOE
| 0O59 | Real-time | |
|
Bulgaria S.E.
| SNW | End-of-day quote | |
|
London S.E.
| 0O59 | Delayed | |
|
Swiss Exchange
| SAN | Delayed |
Last Transcript: Sanofi
| 03:22am | Sanofi : Berenberg remains its Buy rating | ZD |
| Oct. 01 | Sanofi : RBC sticks Neutral | ZD |
| Oct. 01 | Sanofi : JP Morgan reiterates its Neutral rating | ZD |
| Oct. 01 | Sanofi to invest up to $8bn to expand alliance with Regeneron | |
| Oct. 01 | Sanofi : Buy rating from Jefferies | ZD |
| 1 day | +0.89% | ||
| 1 week | -1.93% | ||
| Current month | -2.79% | ||
| 1 month | -7.41% | ||
| 3 months | -6.86% | ||
| 6 months | -14.50% | ||
| Current year | -14.64% |
| 1 week | 69.75 |  | 75.3 |
| 1 month | 69.75 | | 76.19 |
| Current year | 69.75 | | 84.97 |
| 1 year | 69.75 | | 91.15 |
| 3 years | 69.75 | | 110.88 |
| 5 years | 69.75 | | 110.88 |
| 10 years | 62.88 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 56 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/20/26 | Buy | Chief Executive Officer | 1,506 | 0.0001% | ||
| 8/20/26 | Buy | Head of Human Resources | 54 | 0.0000% | ||
| 8/20/26 | Buy | Executive/Senior Manager | 840 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.89% | -1.93% | -18.65% | -31.35% | 93.99B | |
| +1.26% | -2.29% | +36.97% | +104.79% | 1,019B | |
| +0.73% | -4.78% | +35.41% | +61.62% | 610B | |
| +0.35% | +1.29% | +15.86% | +79.90% | 470B | |
| +1.72% | -4.92% | +59.84% | +36.64% | 344B | |
| +0.26% | -1.58% | +21.97% | +41.79% | 336B | |
| +0.60% | -3.48% | +11.37% | +34.33% | 266B | |
| +1.65% | -4.27% | -5.47% | +9.69% | 241B | |
| -0.09% | -4.97% | +36.88% | +50.52% | 218B | |
| -0.28% | -4.66% | +26.99% | +92.98% | 179B | |
| Average | +0.72% | -3.54% | +22.12% | +48.09% | 377.68B | |
| Weighted average by Cap. | +0.88% | -3.49% | +28.46% | +64.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.68B 53.71B 44.62B 40.44B 76.37B 5,177B 76.93B 536B 208B 2,641B 202B 197B 8,491B | 50.65B 57.06B 47.4B 42.96B 81.14B 5,500B 81.73B 569B 221B 2,806B 214B 210B 9,021B |
| Net income | 7.48B 8.43B 7B 6.35B 11.99B 813B 12.07B 84.1B 32.71B 415B 31.64B 30.96B 1,333B | 8.91B 10.03B 8.33B 7.55B 14.27B 967B 14.37B 100B 38.93B 493B 37.66B 36.85B 1,586B |
| Net Debt | 12.13B 13.66B 11.35B 10.29B 19.43B 1,317B 19.57B 136B 53.02B 672B 51.29B 50.19B 2,160B | 8.78B 9.89B 8.21B 7.44B 14.06B 953B 14.16B 98.64B 38.36B 486B 37.11B 36.31B 1,563B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-06 | €70.61 | +0.89% | 1,892,953 |
| 26-10-05 | €69.99 | -1.16% | 1,953,595 |
| 26-10-02 | €70.81 | -3.13% | 3,817,639 |
| 26-10-01 | €73.10 | +0.63% | 3,606,752 |
| 26-09-30 | €72.64 | +1.64% | 3,063,193 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
